Pharma company Strides Arcolab profits were up 31 per cent to Rs 91 crore for the first quarter of the current fiscal because of higher injectables sales. The company's revenues increased 30 per cent to Rs 547 crore (normalised excluding Ascent business). The company's earnings per share rose 30 per cent to Rs 15.43.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.